Masami Shimizu-Albergine, research scientist, is lead author and Dr. Karin Bornfeldt, professor (Metabolism, Endocrinology and Nutrition) is senior author of “CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins” in the Journal of Clinical Investigation. DOM co-authors are Jenny Kanter, Farah Kramer, Vishal Kothari, Shelley Barnhart, Carissa Thornock, Noemie Clouet-Foraison, Tomas Vaisar, and Jay Heinecke.